Skip to main content
Clinical Trials/CTRI/2018/05/013908
CTRI/2018/05/013908Not yet recruiting未知

Role of intralesional vitamin D3 injection in the treatment of cutaneous warts

Dr Shrini Parikh0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 patients having cutaneous warts
  • 2 patients > 18 years
  • 3 patients with no prior treatment with either topical or destructive modalities for atleast 6 months

Exclusion Criteria

  • 1 patients < 18 years
  • 2 pregnant and lactating females
  • 3 any evidence of immunosuppression including HIV
  • 4 prior history of hypersensitivity to vitamin D3
  • 5 previously diagnosed renal disease

Investigators

Sponsor
Dr Shrini Parikh

Similar Trials